SCHEMBL7000985

SCHEMBL7000985

CC1Oc2ccc(-c3ccccc3)cc2NC1=S

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
GAA P10253 3/20 0.54
CHRM1 P11229 3/20 0.42
PARP1 P09874 3/20 0.41
PGR P06401 3/20 0.40
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
MAPT P10636 3/20 0.37
NPC1 O15118 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
HTR2B P41595 2/20 0.36
TMEM97 Q5BJF2 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
HTR7 P34969 1/20 0.36
NR3C1 P04150 1/20 0.34
NR3C2 P08235 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711311 0.84 CYP11B1 (0.48) CHRM1PDE3BPDE3AALDH1A1
SCHEMBL7001705 0.82 PARP1 (0.64) KDM4EKMT2AMEN1GAAPARP1
SCHEMBL7711118 0.80 KCNH2 (0.40) KDM4EKMT2AMEN1GAAPARP1
SCHEMBL7710771 0.79 KCNH2 (0.41) KDM4EKMT2AMEN1GAAPARP1
SCHEMBL7710955 0.78 MAOA (0.40) KDM4EKMT2APARP1MAOAMAOB
SCHEMBL7001759 0.78 PARP1 (0.53) CHRM1PARP1
SCHEMBL7988135 0.78 BRD4 (0.53) KMT2AMEN1GAAPARP1MAPT
SCHEMBL7711230 0.76 PARP1 (0.37) CHRM1PARP1PDE3BPDE3A
SCHEMBL7984345 0.76 HSD17B10 (0.43) CHRM1PARP1PGRPDE3BPDE3A
SCHEMBL7000474 0.76 PARP1 (0.37) KDM4EKMT2AMEN1GAAPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed